Kessler Topaz Meltzer & Check, LLP (KTMC) has announced a securities class action lawsuit against Edwards Lifesciences Corporation (NYSE: EW) in the United States District Court for the Central District of California.
The lawsuit involves allegations of misleading statements about Edwards’ Transcatheter Aortic Valve Replacement (TAVR) platform, filed on behalf of investors who acquired securities during the Class Period (February 6, 2024, to July 24, 2024). The deadline to file as lead plaintiff is December 13, 2024.
Key Highlights of Edwards Lifesciences Corporation Class Action
- Lawsuit Details
- Filed in the United States District Court for the Central District of California.
- Represents investors who acquired Edwards securities between February 6, 2024, and July 24, 2024.
- Investors who suffered losses during this period are encouraged to join the lawsuit.
- Allegations Against Edwards Lifesciences
- Misrepresented the performance of its Transcatheter Aortic Valve Replacement (TAVR) system.
- Overestimated TAVR’s potential based on inaccurate assumptions about adoption rates and patient demographics.
- Allegations of relying on faulty data to project the success of its TAVR platform.
- Investor Options
- Eligible investors can apply as lead plaintiffs to manage the litigation process.
- Investors can choose to stay outside the lead plaintiff role while remaining eligible for potential recovery.
- Contact attorney Jonathan Naji, Esq. at (484) 270-1453 or email [email protected] for further information.
- Important Deadline
- The final date to seek lead plaintiff status is December 13, 2024.
About Edwards Lifesciences Corporation
Founded in 1958 and headquartered in Irvine, California, Edwards Lifesciences is a global leader in heart valve disease and critical care monitoring. Key highlights include:
- Innovative technologies for cardiovascular treatments, particularly the Transcatheter Aortic Valve Replacement (TAVR) system.
- Presence in 100+ countries and publicly traded on NYSE under EW.
- Other product lines: surgical heart valves, heart valve repair solutions, and hemodynamic monitoring equipment.
About Kessler Topaz Meltzer & Check, LLP (KTMC)
Kessler Topaz Meltzer & Check, LLP (KTMC) is renowned for its expertise in class-action lawsuits and has recovered billions of dollars for victims of corporate misconduct and fraud. With a global reputation, the firm actively prosecutes cases in state and federal courts across the United States and internationally. For more details, visit the firm’s official website: www.ktmc.com.
How to Act
Investors affected by Edwards Lifesciences Corporation’s alleged misstatements are urged to act quickly to meet the December 13, 2024, deadline. For further assistance:
- Contact: Jonathan Naji, Esq.
- Phone: (484) 270-1453
- Email: [email protected]
By participating in this lawsuit, investors have the opportunity to recover potential losses and hold Edwards accountable for any alleged misconduct.
PV Martinez holds an MBA in Finance from the University of Michigan. When not analyzing numbers, PV enjoys playing football and spending time singing his favorite tunes.